Newswise — OMAHA, Ne. (Feb. 5, 2020) – The director of Creighton University’s Hereditary Cancer Center recently published research on a new drug that holds exciting possibilities for the treatment of cancers and many other diseases.
Robin Farias-Eisner, MD, PhD, alongside Srinivasa Reddy, PhD, from the University of California, Los Angeles, spearheaded research that led to the January publication of “Bovine HDL and Dual Domain HDL-Mimetic Peptides Inhibit Tumor Development in Mice” in the Journal of Cancer Research and Therapeutic Oncology.
Co-authored by Farias-Eisner and Holly Stessman, PhD, assistant professor in Creighton School of Medicine’s Department of Pharmacology, alongside Reddy and other researchers at UCLA, the paper outlines how HM-10/10, a drug developed from proteins used to diagnose ovarian cancer, has been effective in inhibiting tumor…
